Find a job 
Featured Companies 
Featured Universities 
For Companies 
Guardant Health
About Guardant Health
Guardant Health is a pioneering precision oncology company dedicated to transforming cancer care through innovative blood tests. Founded with the vision of improving patient outcomes, the company focuses on providing comprehensive genomic insights that empower oncologists and patients alike.
At the core of Guardant Health’s mission is the development of non-invasive liquid biopsy tests that detect and monitor cancer through a simple blood draw. These tests are designed to identify genetic mutations and alterations in circulating tumor DNA (ctDNA), enabling personalized treatment strategies tailored to individual patients.
Guardant Health’s flagship product, Guardant360, is widely recognized for its ability to provide actionable genomic information across various cancer types. This test not only aids in treatment selection but also plays a crucial role in monitoring disease progression and response to therapy.
The company is committed to advancing cancer research and has established partnerships with leading academic institutions and pharmaceutical companies. Through these collaborations, Guardant Health aims to enhance the understanding of cancer biology and contribute to the development of new therapies.
Guardant Health operates with a strong emphasis on innovation, continuously investing in research and development to expand its product offerings. The company’s state-of-the-art laboratory facilities are equipped with cutting-edge technology, ensuring the highest standards of accuracy and reliability in testing.
In addition to its focus on technology, Guardant Health prioritizes patient education and support. The company provides resources and guidance to help patients navigate their cancer journey, fostering a community of informed individuals who can make empowered decisions about their health.
With a commitment to excellence and a passion for improving lives, Guardant Health is at the forefront of the fight against cancer, striving to make precision medicine accessible to all patients worldwide.